Suchergebnisse - "Herrington, William G"

PubPharm (11)

1

SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease : a comprehensive review by EURECA-m and ERBP working groups of ERA

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023

von Mark, P. | Sarafidis, P. | Ekart, R. | +11

2

UK Kidney Association Clinical Practice Guideline : Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE

enthalten in: BMC nephrology | 2023

von Roddick, A. | Wonnacott, A. | Webb, D. | +15

3

Bioimpedance Indices of Fluid Overload and Cardiorenal Outcomes in Heart Failure and Chronic Kidney Disease : a Systematic Review

enthalten in: Journal of cardiac failure | 2022

von Mayne, K. | Shemilt, R. | Keane, D. | +3

4

Chronic kidney disease, heart failure and neprilysin inhibition

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2020

von Haynes, R. | Zhu, D. | Judge, P. | +3

5

Kidney disease trials for the 21st century : innovations in design and conduct

enthalten in: Nature reviews. Nephrology | 2020

von Herrington, W. | Staplin, N. | Haynes, R.

6

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease : a rationale for the EMPA-KIDNEY study

enthalten in: Clinical kidney journal | 2018

von Herrington, W. | Preiss, D. | Haynes, R. | +8

ErratumIn: Clin Kidney J. 2019 Feb 11;13(4):722. - PMID 32905262

7

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases : A Meta-Analysis

enthalten in: Journal of the American Society of Nephrology : JASN | 2018

von Marthi, A. | Donovan, K. | Haynes, R. | +11

8

Cardiovascular Outcomes Reported in Hemodialysis Trials

enthalten in: Journal of the American College of Cardiology | 2018

von O'Lone, E. | Viecelli, A. | Craig, J. | +19

9

The Role of Emerging Risk Factors in Cardiovascular Outcomes

enthalten in: Current atherosclerosis reports | 2017

von Lacey, B. | Herrington, W. | Preiss, D. | +2

10

Metformin : the safest hypoglycaemic agent in chronic kidney disease?

enthalten in: Nephron. Clinical practice | 2011

von Nye, H. | Herrington, W.